Monument Therapeutics
Monument Therapeutics started as a research project within Cambridge Cognition to develop a better way to stratify patients based on measurable brain function rather than broad diagnoses and, therefore, create more homogeneous patient groups that would respond predictably to specific treatments.
Monument Therapeutics has raised €1.0M across 1 funding round from 4 investors, most recently a round in Feb 2025. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKmonumenttx.com ↗
Total raised
€1.0M
€1,025,233
Funding rounds
1
Investors
4
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearMonument Therapeutics — funding by year — interactive chart.
Data table
| Monument Therapeutics — funding by year | |
|---|---|
| 2025 | €1.0M |
Signals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-25 | Other | €1.0M | ACF investors,Angel Investors,o2h Ventures,Wren Capital | View deal → |